Emotion Recognition Deficits in the Differential Diagnosis of Amnestic Mild Cognitive Impairment: A Cognitive Marker for the Limbic-Predominant Phenotype. (22nd February 2022)
- Record Type:
- Journal Article
- Title:
- Emotion Recognition Deficits in the Differential Diagnosis of Amnestic Mild Cognitive Impairment: A Cognitive Marker for the Limbic-Predominant Phenotype. (22nd February 2022)
- Main Title:
- Emotion Recognition Deficits in the Differential Diagnosis of Amnestic Mild Cognitive Impairment: A Cognitive Marker for the Limbic-Predominant Phenotype
- Authors:
- Dodich, Alessandra
Crespi, Chiara
Santi, Gaia Chiara
Marcone, Alessandra
Iannaccone, Sandro
Perani, Daniela
Cappa, Stefano F.
Cerami, Chiara - Abstract:
- Abstract: Objective: Late-onset amnestic mild cognitive impairment (aMCI) with long disease course and slow progression has been recently recognized as a possible phenotypical expression of a limbic-predominant neurodegenerative disorder. Basic emotion recognition ability crucially depending on temporo-limbic integrity is supposed to be impaired in this group of MCI subjects presenting a selective vulnerability of medio-temporal and limbic regions. However, no study specifically investigated this issue. Methods: Hereby, we enrolled 30 aMCI with a biomarker-based diagnosis of Alzheimer's disease (i.e., aMCI-AD, n = 16) or a biomarker evidence of selective medio-temporal and limbic degeneration (aMCI-mTLD, n = 14). Ekman-60 Faces Test (Ek-60F) was administered to each subject, comparing the performance with that of 20 healthy controls (HCs). Results: aMCI-mTLD subjects showed significantly lower Ek-60F global scores compared to HC (p = 0.001), whose performance was comparable to aMCI-AD. Fear (p = 0.02), surprise (p = 0.005), and anger (p = 0.01) recognition deficits characterized the aMCI-mTLD performance. Fear recognition scores were significantly lower in aMCI-mTLD compared to aMCI-AD (p = 0.04), while no differences were found in other emotions. Conclusions: Impaired social cognition, suggested by defective performance in emotion recognition tasks, may be a useful cognitive marker to detect limbic-predominant aMCI subjects among the heterogeneous aMCI population.
- Is Part Of:
- Journal of the International Neuropsychological Society. Volume 28:Number 2(2022)
- Journal:
- Journal of the International Neuropsychological Society
- Issue:
- Volume 28:Number 2(2022)
- Issue Display:
- Volume 28, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 28
- Issue:
- 2
- Issue Sort Value:
- 2022-0028-0002-0000
- Page Start:
- 203
- Page End:
- 209
- Publication Date:
- 2022-02-22
- Subjects:
- Mild cognitive impairment -- Ekman 60 Faces test -- cognitive marker -- differential diagnosis -- medial temporal lobe dysfunction -- Alzheimer's disease
Neuropsychology -- Periodicals
616.8 - Journal URLs:
- http://journals.cambridge.org/action/displayJournal?jid=INS ↗
- DOI:
- 10.1017/S1355617721000254 ↗
- Languages:
- English
- ISSNs:
- 1355-6177
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 20675.xml